Psychedelics stocks traded higher on Thursday as investor optimism returned to the sector on the news that...
15.24 Thu 07 Mar 2024
Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share news the company had a successful 2023, with a final tally of 164 million USD, which is at the upper end of their forecast. The company concluded the year with 72 million USD in cash, surpassing their initial projections...